37 related articles for article (PubMed ID: 38717526)
1. VDX-111 targets proliferative pathways in canine cancer cell lines.
Farrell KB; Das S; Nordeen SK; Lambert JR; Thamm DH
PLoS One; 2024; 19(5):e0303470. PubMed ID: 38771847
[TBL] [Abstract][Full Text] [Related]
2. Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway.
Lu Y; Wang H; Chen S; Yang B; Li Y; Li Y
J Cancer Res Clin Oncol; 2024 May; 150(5):244. PubMed ID: 38717526
[TBL] [Abstract][Full Text] [Related]
3. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
4. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer.
Qu X; Liu B; Wang L; Liu L; Zhao W; Liu C; Ding J; Zhao S; Xu B; Yu H; Zhang X; Chai J
Drug Resist Updat; 2023 May; 68():100936. PubMed ID: 36764075
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer.
Fong C; Johnston E; Starling N
Curr Treat Options Oncol; 2022 Sep; 23(9):1247-1268. PubMed ID: 35980522
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Lordick F; Carneiro F; Cascinu S; Fleitas T; Haustermans K; Piessen G; Vogel A; Smyth EC;
Ann Oncol; 2022 Oct; 33(10):1005-1020. PubMed ID: 35914639
[No Abstract] [Full Text] [Related]
7. Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for Colorectal Cancer.
Xie Q; Liu L; Chen X; Cheng Y; Li J; Zhang X; Xu N; Han Y; Liu H; Wei L; Peng J; Shen A
J Cancer; 2021; 12(17):5144-5152. PubMed ID: 34335931
[TBL] [Abstract][Full Text] [Related]
8. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
9. TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway.
Yu X; Li S; Pang M; Du Y; Xu T; Bai T; Yang K; Hu J; Zhu S; Wang L; Liu X
Front Oncol; 2020; 10():613869. PubMed ID: 33489923
[TBL] [Abstract][Full Text] [Related]
10. The rediscovery of platinum-based cancer therapy.
Rottenberg S; Disler C; Perego P
Nat Rev Cancer; 2021 Jan; 21(1):37-50. PubMed ID: 33128031
[TBL] [Abstract][Full Text] [Related]
11. Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells.
Braicu C; Zanoaga O; Zimta AA; Tigu AB; Kilpatrick KL; Bishayee A; Nabavi SM; Berindan-Neagoe I
Semin Cancer Biol; 2022 May; 80():218-236. PubMed ID: 32502598
[TBL] [Abstract][Full Text] [Related]
12. A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies.
Cheng A; Zhao S; FitzGerald LM; Wright JL; Kolb S; Karnes RJ; Jenkins RB; Davicioni E; Ostrander EA; Feng Z; Fan JB; Dai JY; Stanford JL
Prostate; 2019 Oct; 79(14):1589-1596. PubMed ID: 31376183
[TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.
Alzahrani AS
Semin Cancer Biol; 2019 Dec; 59():125-132. PubMed ID: 31323288
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
Bao Y; Wang L; Shi L; Yun F; Liu X; Chen Y; Chen C; Ren Y; Jia Y
Cell Mol Biol Lett; 2019; 24():38. PubMed ID: 31182966
[TBL] [Abstract][Full Text] [Related]
15. Akt in cancer: Mediator and more.
Revathidevi S; Munirajan AK
Semin Cancer Biol; 2019 Dec; 59():80-91. PubMed ID: 31173856
[TBL] [Abstract][Full Text] [Related]
16. AKT1
Kircher DA; Trombetti KA; Silvis MR; Parkman GL; Fischer GM; Angel SN; Stehn CM; Strain SC; Grossmann AH; Duffy KL; Boucher KM; McMahon M; Davies MA; Mendoza MC; VanBrocklin MW; Holmen SL
Mol Cancer Res; 2019 Sep; 17(9):1787-1800. PubMed ID: 31138602
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis.
Cui Y; Sun D; Song R; Zhang S; Liu X; Wang Y; Meng F; Lan Y; Han J; Pan S; Liang S; Zhang B; Guo H; Liu Y; Lu Z; Liu L
J Cell Physiol; 2019 Dec; 234(12):22623-22634. PubMed ID: 31106426
[TBL] [Abstract][Full Text] [Related]
18. Targeted literature review of the global burden of gastric cancer.
Casamayor M; Morlock R; Maeda H; Ajani J
Ecancermedicalscience; 2018; 12():883. PubMed ID: 30679950
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
